Abstract
A series of novel spiro-piperidinyl pyrazolones were synthesized starting from the commercially available ethyl nipecotate. The Boc protected ethyl nipecotate was reacted with 5-bromo-2-furaldehyde in the presence of LDA to afford the β -hydroxy ester which was converted to the β -keto ester by oxidation using manganese dioxide. Furthermore, β-keto ester was treated with hydrazine to form the spiro-piperidinyl pyrazolone scaffold. The phenyl/heteroaryl substituted (6ai) and hetero/arylethynyl substituted (7a-d) spiro pyrazolone were prepared by Suzuki and Sonogashira coupling followed by deprotection of the protecting group. All the synthesized compounds were evaluated for their invitro antiviral activity against BPXV on Vero cells. Compound 6c, 6d and 7c in the series showed potent antiviral activity.
Keywords: Spiro piperidines, pyrazolones, aryl furan, suzuki coupling, sonogashira coupling, antiviral activity.
Letters in Drug Design & Discovery
Title:Design and Synthesis of Novel Spiro-Piperidinyl Pyrazolone Derivatives and Their Potential Antiviral Activity
Volume: 13 Issue: 2
Author(s): Rajagopalan Srinivasan, Badiadka Narayana, Balladka Kunhanna Sarojini, Veerakyathappa Bhanuprakash, Chenna Govindaraju Darshan Raj and Prakash S. Nayak
Affiliation:
Keywords: Spiro piperidines, pyrazolones, aryl furan, suzuki coupling, sonogashira coupling, antiviral activity.
Abstract: A series of novel spiro-piperidinyl pyrazolones were synthesized starting from the commercially available ethyl nipecotate. The Boc protected ethyl nipecotate was reacted with 5-bromo-2-furaldehyde in the presence of LDA to afford the β -hydroxy ester which was converted to the β -keto ester by oxidation using manganese dioxide. Furthermore, β-keto ester was treated with hydrazine to form the spiro-piperidinyl pyrazolone scaffold. The phenyl/heteroaryl substituted (6ai) and hetero/arylethynyl substituted (7a-d) spiro pyrazolone were prepared by Suzuki and Sonogashira coupling followed by deprotection of the protecting group. All the synthesized compounds were evaluated for their invitro antiviral activity against BPXV on Vero cells. Compound 6c, 6d and 7c in the series showed potent antiviral activity.
Export Options
About this article
Cite this article as:
Srinivasan Rajagopalan, Narayana Badiadka, Kunhanna Sarojini Balladka, Bhanuprakash Veerakyathappa, Darshan Raj Chenna Govindaraju and S. Nayak Prakash, Design and Synthesis of Novel Spiro-Piperidinyl Pyrazolone Derivatives and Their Potential Antiviral Activity, Letters in Drug Design & Discovery 2016; 13 (2) . https://dx.doi.org/10.2174/1570180812666150630182740
DOI https://dx.doi.org/10.2174/1570180812666150630182740 |
Print ISSN 1570-1808 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-628X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Phosphodiesterase Type 5 Inhibitor Abuse: A Critical Review
Current Drug Abuse Reviews APO2L/TRAIL: New Insights in the Treatment of Autoimmune Disorders
Recent Patents on Inflammation & Allergy Drug Discovery Emerging Role of Apelin as a Therapeutic Target in Cancer: A Patent Review
Recent Patents on Anti-Cancer Drug Discovery Immunomodulatory Effects of Soybeans and Processed Soy Food Compounds
Recent Patents on Food, Nutrition & Agriculture Chemopreventive Properties of Peptide Lunasin: A Review
Protein & Peptide Letters The Potential of PDE4 Inhibitors in Respiratory Disease
Current Drug Targets - Inflammation & Allergy Intestinal Barrier Dysfunction in Human Pathology and Aging
Current Pharmaceutical Design Nuclear Medicine Application of Pentixafor/Pentixather Targeting CXCR4 for Imaging and Therapy in Related Disease
Mini-Reviews in Medicinal Chemistry Management of Anaphylaxis in Pediatric Population
Current Pharmaceutical Design Empagliflozin for Type 2 Diabetes Mellitus: An Overview of Phase 3 Clinical Trials
Current Diabetes Reviews Neuropsychiatric Systemic Lupus Erythematosus
Current Neuropharmacology From 2D to 3D - a New Dimension for Modelling the Effect of Natural Products on Human Tissue
Current Pharmaceutical Design Molecular Mechanisms of Membrane Perturbation by Antimicrobial Peptides and the Use of Biophysical Studies in the Design of Novel Peptide Antibiotics
Combinatorial Chemistry & High Throughput Screening Cachexia and Herbal Medicine: Perspective
Current Pharmaceutical Design Editorial from Guest Editor [Hot topic: Novel Inflammatory Biomarkers in Diseases (Guest Editor: Yu Chen)]
Inflammation & Allergy - Drug Targets (Discontinued) Molecular Phenotype of CXCL12β 3UTR G801A Polymorphism (rs1801157) Associated to HIV-1 Disease Progression
Current HIV Research Glucagon Like Peptide-1 (GLP-1) Dynamics Following Bariatric Surgery: A Signpost to a New Frontier
Current Diabetes Reviews Cell Immunity in Inflammatory Vasculitis
Current Immunology Reviews (Discontinued) ARC - Augmented Renal Clearance
Current Pharmaceutical Biotechnology Chalcone Derivatives: Anti-inflammatory Potential and Molecular Targets Perspectives
Current Topics in Medicinal Chemistry